Free tool
Diagnostics stocks
We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $18.20M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −43.0% to −3.3% across the middle 80 percent of the group, with a median of −29.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| SBS.DE | Stratec SE | $333.46M | Small cap | −14.89% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $181.91M | Small cap | +22.40% |
| BVXP.L | Bioventix PLC | $117.85M | Small cap | −30.64% |
| RENX.L | Renalytix Plc | $24.64M | Micro cap | −27.35% |
| GENI.L | GENinCode Plc | $11.77M | Micro cap | −14.29% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.02M | Micro cap | −41.54% |
| BMRA | Biomerica, Inc. | $5.22M | Micro cap | −46.35% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.